26 (PB014): Development of Tumour-specific CD146 CAR-T Cells for Targeted Cancer Immunotherapy of Solid Tumours

IF 7.6 1区医学 Q1 ONCOLOGY European Journal of Cancer Pub Date : 2024-10-01 DOI:10.1016/j.ejca.2024.114554

E. Uzuner, H. Mole, S. Gurler, C. Wong, M.L. Fernandez Carro, R. Leshem, K. Sefton, H. Tovey, A. Picken, M. Blot-Chabaud, A. Hurlstone

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

26 (PB014)：开发用于实体瘤靶向癌症免疫疗法的肿瘤特异性 CD146 CAR-T 细胞

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

European Journal of Cancer 医学-肿瘤学

CiteScore

11.50

自引率

4.80%

发文量

953

审稿时长

23 days

期刊介绍： The European Journal of Cancer (EJC) serves as a comprehensive platform integrating preclinical, digital, translational, and clinical research across the spectrum of cancer. From epidemiology, carcinogenesis, and biology to groundbreaking innovations in cancer treatment and patient care, the journal covers a wide array of topics. We publish original research, reviews, previews, editorial comments, and correspondence, fostering dialogue and advancement in the fight against cancer. Join us in our mission to drive progress and improve outcomes in cancer research and patient care.

期刊最新文献

Editorial Board Small-RNA sequencing reveals potential serum biomarkers for gallbladder cancer: Results from a three-stage collaborative study of large European prospective cohorts Patient access to perioperative chemotherapy with fluorouracil, leucovorin, oxaliplatin and docetaxel in patients with resectable gastric cancer in the Netherlands Sex differences in toxicities and survival outcomes among Japanese patients with Stage III colorectal cancer receiving adjuvant fluoropyrimidine monotherapy: A pooled analysis of 4 randomized controlled trials (JCOG2310A) Panacreatic cancer risk after benign gallbladder disease: A Swedish population-based cohort study